Price (delayed)
$3.92
Market cap
$24.6M
P/E Ratio
N/A
Dividend/share
$0.32
EPS
-$3.88
Enterprise value
$24.35M
AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.